Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) has provided an announcement.
Fisher & Paykel Healthcare Corporation Limited announced a change in the shareholding of its director, Graham Andrew McLean, who increased his beneficial interest by purchasing 1,000 ordinary shares at AUD 33.90 per share. This transaction reflects ongoing confidence in the company’s performance and may impact its market perception positively, signaling strong internal belief in the company’s future prospects.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited operates in the healthcare industry, specializing in the design, manufacture, and marketing of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. The company focuses on improving patient care and outcomes through innovative healthcare solutions.
See more insights into FSPKF stock on TipRanks’ Stock Analysis page.

